Mouse mAbs directed against FH used in this study
| Designation . | Isotype . | Epitope location (CCP domain)* . | Cross-reactivity . | Functional effect† . |
|---|---|---|---|---|
| Anti-FH.02 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |
| Anti-FH.03 | Mouse IgG1, κ | Unknown | FHL-1 | Weak inhibition |
| Anti-FH.07 | Mouse IgG1, κ | 18 | FHR-1 | Potentiation |
| Anti-FH.09 | Mouse IgG1, κ | 6 | FHL-1, FHR-3, FHR-4A | Strong inhibition |
| Anti-FH.10 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |
| Anti-FH.11 | Mouse IgG2a, κ | 1-4 | FHL-1 | Strong inhibition‡ |
| Anti-FH.15 | Mouse IgG1, κ | 5 | FHL-1 | Strong inhibition |
| Anti-FH.16 | Mouse IgG1, κ | 16-17 | None | Weak inhibition |
| Anti-FH.19 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |
| Designation . | Isotype . | Epitope location (CCP domain)* . | Cross-reactivity . | Functional effect† . |
|---|---|---|---|---|
| Anti-FH.02 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |
| Anti-FH.03 | Mouse IgG1, κ | Unknown | FHL-1 | Weak inhibition |
| Anti-FH.07 | Mouse IgG1, κ | 18 | FHR-1 | Potentiation |
| Anti-FH.09 | Mouse IgG1, κ | 6 | FHL-1, FHR-3, FHR-4A | Strong inhibition |
| Anti-FH.10 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |
| Anti-FH.11 | Mouse IgG2a, κ | 1-4 | FHL-1 | Strong inhibition‡ |
| Anti-FH.15 | Mouse IgG1, κ | 5 | FHL-1 | Strong inhibition |
| Anti-FH.16 | Mouse IgG1, κ | 16-17 | None | Weak inhibition |
| Anti-FH.19 | Mouse IgG1, κ | 20 | FHR-1 | Strong inhibition |